217 related articles for article (PubMed ID: 26279373)
1. The Bone Morphogenetic Proteins and Their Antagonists.
Mulloy B; Rider CC
Vitam Horm; 2015; 99():63-90. PubMed ID: 26279373
[TBL] [Abstract][Full Text] [Related]
2. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic proteins, their antagonists, and the skeleton.
Canalis E; Economides AN; Gazzerro E
Endocr Rev; 2003 Apr; 24(2):218-35. PubMed ID: 12700180
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin.
Groppe J; Greenwald J; Wiater E; Rodriguez-Leon J; Economides AN; Kwiatkowski W; Affolter M; Vale WW; Izpisua Belmonte JC; Choe S
Nature; 2002 Dec; 420(6916):636-42. PubMed ID: 12478285
[TBL] [Abstract][Full Text] [Related]
5. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN.
Reddi AH
Arthritis Res; 2001; 3(1):1-5. PubMed ID: 11178121
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists.
Avsian-Kretchmer O; Hsueh AJ
Mol Endocrinol; 2004 Jan; 18(1):1-12. PubMed ID: 14525956
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists.
Rider CC; Mulloy B
Biochem J; 2010 Jul; 429(1):1-12. PubMed ID: 20545624
[TBL] [Abstract][Full Text] [Related]
8. Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily.
Rider CC; Mulloy B
Molecules; 2017 Apr; 22(5):. PubMed ID: 28468283
[TBL] [Abstract][Full Text] [Related]
9. BMP signalling: agony and antagony in the family.
Brazil DP; Church RH; Surae S; Godson C; Martin F
Trends Cell Biol; 2015 May; 25(5):249-64. PubMed ID: 25592806
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein.
Groppe J; Greenwald J; Wiater E; Rodriguez-Leon J; Economides AN; Kwiatkowski W; Baban K; Affolter M; Vale WW; Izpisua Belmonte JC; Choe S
J Bone Joint Surg Am; 2003; 85-A Suppl 3():52-8. PubMed ID: 12925610
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of BMP-Receptor Interaction and Activation.
Mueller TD
Vitam Horm; 2015; 99():1-61. PubMed ID: 26279372
[TBL] [Abstract][Full Text] [Related]
13. Twisted gastrulation can function as a BMP antagonist.
Chang C; Holtzman DA; Chau S; Chickering T; Woolf EA; Holmgren LM; Bodorova J; Gearing DP; Holmes WE; Brivanlou AH
Nature; 2001 Mar; 410(6827):483-7. PubMed ID: 11260717
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
15. Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily.
Rider CC
Biochem Soc Trans; 2006 Jun; 34(Pt 3):458-60. PubMed ID: 16709187
[TBL] [Abstract][Full Text] [Related]
16. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms.
Zhang JL; Huang Y; Qiu LY; Nickel J; Sebald W
J Biol Chem; 2007 Jul; 282(27):20002-14. PubMed ID: 17483092
[TBL] [Abstract][Full Text] [Related]
18. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease.
Tobin JF; Celeste AJ
Drug Discov Today; 2006 May; 11(9-10):405-11. PubMed ID: 16635802
[TBL] [Abstract][Full Text] [Related]
20. The role of chordin fragments generated by partial tolloid cleavage in regulating BMP activity.
Troilo H; Barrett AL; Wohl AP; Jowitt TA; Collins RF; Bayley CP; Zuk AV; Sengle G; Baldock C
Biochem Soc Trans; 2015 Oct; 43(5):795-800. PubMed ID: 26517884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
